Abstract
Objective: To analyze the management of lipedema, from diagnosis to treatment, considering the available healthcare strategies and the challenges for its adequate approach. Literature review: Lipedema is a chronic condition characterized by abnormal subcutaneous fat deposition, often mistaken for obesity or lymphedema. Its pathophysiology involves hormonal, genetic, and metabolic factors, progressing through distinct stages with significant physical, emotional, and social impacts on patients' quality of life. In primary care, early diagnosis is critical, despite challenges related to knowledge gaps and resource limitations. Therapeutic strategies include lymphatic drainage, compression therapy, and psychological support, with referrals for advanced treatments, such as liposuction, being necessary. Telemedicine and the development of specific guidelines are emphasized as tools to improve management. Final considerations: Primary care plays a vital role in the early recognition and care coordination of patients with lipedema. Investing in professional training, developing national protocols, and strengthening multidisciplinary approaches are essential strategies to improve clinical outcomes and patient quality of life.
References
ALOSAIMI K, et al. Characteristics and clinical features of patients with lipedema in Saudi Arabia: A cross-sectional comprehensive assessment. Plastic and Reconstructive Surgery. Global Open, 2024; 12(9): 6173.
AMATO ACM, et al. Ultrasound criteria for lipedema diagnosis. Phlebology, 2021; 36(8): 651–658.
ANNE WARREN PELED A, et al. Lipedema: diagnostic and management challenges. International Journal of Women’s Health, 2016; 8: 389–395.
ARTEMOVA AS, et al. Lipedema: a professional community’s view. Rossiiskii Meditsinskii Zhurnal: Organ Ministerstva Zdravookhraneniia RSFSR, 2023; 29(6): 467–474.
BUCK DW e HERBST KL. Lipedema: A relatively common disease with extremely common misconceptions. Plastic and Reconstructive Surgery. Global Open, 2016; 4(9): 1043.
BUSO G, et al. Lipedema: A call to action! Obesity (Silver Spring, Md.), 2019; 27(10): 1567–1576.
CÂMARA B, et al. Lipedema: Um problema subdiagnosticado. Gazeta Médica, 2024; 255–256.
CARBALLEIRA BRAÑA A e POVEDA CASTILLO J. The advanced care study: Current status of lipedema in Spain, A descriptive cross-sectional study. International Journal of Environmental Research and Public Health, 2023; 20(17).
CHACHAJ A, et al. Disability and emotional symptoms in women with lipedema: A comparison with overweight/obese women. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University, 2024; 33(12): 1367–1377.
ERDEN Y, et al. A surge of interest: Analysing the increased public interest in lipedema using Google Trends. Phlebology, 2024.
ESEN ÖZDEMIR E, et al. YouTube as a source of information on lipedema: Property, quality, and reliability assessment. Lymphatic Research and Biology, 2023; 21(4): 403–409.
ESMER M e SCHINGALE FJ. Can physical therapy techniques slow down the progression of lipedema? Lymphatic Research and Biology, 2024; 22(6): 267–270.
FORNER-CORDERO I, et al. Prevalence of clinical manifestations and orthopedic alterations in patients with lipedema: A prospective cohort study. Lymphology, 2022; 54(4).
FORNER-CORDERO I, et al. Update in the management of lipedema. International Angiology: A Journal of the International Union of Angiology, 2021; 40(4): 345–357.
HALK AB e DAMSTRA RJ. First Dutch guidelines on lipedema using the international classification of functioning, disability and health. Phlebology, 2017; 32(3): 152–159.
HERBST KL, et al. Standard of care for lipedema in the United States. Phlebology, 2021; 36(10): 779–796.
JANTSCH AG, et al. Residency training in family medicine and its impact on coordination and continuity of care: An analysis of referrals to secondary care in Rio de Janeiro. BMJ Open, 2022; 12(2): 51515.
KATZER K, et al. Lipedema and the potential role of estrogen in excessive adipose tissue accumulation. International Journal of Molecular Sciences, 2021; 22(21): 11720.
KRUPPA P, et al. Lipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis. Frontiers in Immunology, 2023; 14.
KRUPPA P, et al. Lipedema-pathogenesis, diagnosis, and treatment options. Deutsches Arzteblatt International, 2020; 117(22–23): 396–403.
LEACH J. A family doctor has a holistic approach. BMJ (Clinical Research Ed.), 2022; 532.
NANKAM PAN, et al. Is subcutaneous adipose tissue expansion in people living with lipedema healthier and reflected by circulating parameters? Frontiers in Endocrinology, 2022; 13.
POOJARIII A, et al. Lipedema: Insights into morphology, pathophysiology, and challenges. Biomedicines, 2022; 10(12): 3081.
RUIZ-SILVA C, et al. Treatment of lipedema using cryolipolysis associated with microcurrents. IOSR Journal of Dental and Medical Sciences, 2024; 23(10): 5–12.
STANGE KC, et al. The role of primary care in improving population health. The Milbank Quarterly, 2023; 101(S1): 795–840.
WHITEBIRD RR, et al. Care coordination in primary care: Views of clinicians and clinic leaders. Journal of Nursing Care Quality, 2025; 40(1): 90–97.
WITTE T, et al. Water-jet-assisted liposuction for the treatment of lipedema: Standardized treatment protocol and results of 63 patients. Journal of Plastic, Reconstructive & Aesthetic Surgery: JPRAS, 2020; 73(9): 1637–1644.
